Project Grant F32AI183805
- This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to use whole genome sequencing (WGS) and diagnostic allele (DA) surveillance to study bacterial infection transmission and persistence dynamics within neonatal intensive care units (NICUs). The $881,303 award will fund research to: Determine patient, pathogen, and environment-specific factors contributing to infection...
- This Project Grant award of $430,760 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) aims to establish a strategy to improve host defense against the gram-negative bacterium Pseudomonas aeruginosa, which poses a serious threat of hospital-acquired infections, especially ventilator-associated pneumonia. The research will investigate how a single low dose of ultrapure LPS can train the...
- This $472,210 Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research grant program (CFDA 93.855), supports research to delineate how prior experience with respiratory pathogens influences susceptibility to subsequent pneumonia infections. The primary objectives are to determine the spatiotemporal relationship between lung CD4+ resident memory T (Trm) cells and recruited neutrophils during pneumonia,...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $249,000 in funding to the Regents of the University of Minnesota to conduct research on defining the mechanisms by which macrophages restrict the spread of Klebsiella pneumoniae (KP) during bacteremia and sepsis. The central hypothesis is that tissue-resident macrophages provide distinct niches that either restrict or...
- The University of Illinois received a $582,350 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) on July 8, 2025 to fund research on "Microbiota-Mediated Colonization Resistance to Acinetobacter baumannii." The project aims to identify gut microbiome "keystone species" that can synergize with a diverse microbiome to prevent colonization by the antibiotic-resistant pathogen A. baumannii. The...
- This Project Grant award of $481,214.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research to define high-risk genomic groups of the bacterium Stenotrophomonas maltophilia. The project aims to investigate strain factors of S. maltophilia that may impact clinical presentation and patient outcomes, as prior research has identified certain genomic groups associated with higher...
- This $450,630 Project Grant was awarded on August 1, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) to Tufts University School of Medicine. The grant supports research to spatiotemporally interrogate the interactions between the Streptococcus pneumoniae virulence factor pneumolysin, pulmonary epithelium, and polymorphonuclear leukocytes (PMNs). The research aims to understand how these interactions contribute to...
- This federal Project Grant award of $417,845.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify novel immune determinants that influence Staphylococcus aureus (S. aureus) biofilm infections, a leading cause of antibiotic-resistant prosthetic joint infections. The research leverages the Collaborative Cross (CC), a genetically diverse panel of mouse strains, to...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $379,609.00 to the University of Pittsburgh under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate B cell central tolerance to a model commensal antigen. The project aims to create molecular and cellular tools to study how the immune system establishes homeostasis with commensal microbes, as B cells must balance maintaining a diverse B cell receptor repertoire while...
- This $540,818 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program supports research on the interdependency of chemical, structural, and physiological heterogeneity in Pseudomonas aeruginosa biofilms. The research aims to define the integrated molecular pathways that allow this opportunistic pathogen to survive in aggregated, slowly growing forms often found in infection sites. Key...
STRATEGIES AND CONSEQUENCES OF POLYMICROBIAL NASAL COLONIZATION - PROJECT SUMMARY THE UPPER RESPIRATORY TRACT IS COLONIZED BY A COMPLEX AND DYNAMIC COMMUNITY OF COMMENSAL BACTERIA AND OPPORTUNISTIC PATHOGENS. AS COLONIZATION IS FREQUENTLY A PREREQUISITE FOR SUBSEQUENT RESPIRATORY INFECTION, THIS RESIDENT FLORA REPRESENTS A CRITICAL RESERVOIR FOR BACTERIAL PATHOGENS RESPONSIBLE FOR SINUSITIS, ACUTE OTITIS MEDIA, AND PNEUMONIA. AMONG THE LEADING AGENTS OF COMMUNITY-ACQUIRED PNEUMONIA ARE STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE, MORAXELLA CATARRHALIS, AND STAPHYLOCOCCUS AUREUS, ALL OF WHICH ARE HIGHLY EFFECTIVE IN COLONIZING THE UPPER RESPIRATORY TRACT OF ASYMPTOMATIC INDIVIDUALS. COLONIZATION OF THE RESPIRATORY TRACT IS OFTEN POLYMICROBIAL WITH INTENSE COMPETITION FOR LIMITED NUTRITIONAL RESOURCES, RESULTING IN BOTH SYNERGISTIC AND ANTAGONISTIC INTERACTIONS BETWEEN OR WITHIN SPECIES. WHILE OUR UNDERSTANDING OF THE BACTERIAL AND HOST FACTORS CONTRIBUTING TO COLONIZATION OF THE UPPER RESPIRATORY TRACT HAS ADVANCED CONSIDERABLY, A KEY ASPECT THAT REMAINS UNRESOLVED IS AN UNDERSTANDING OF HOW POLYMICROBIAL INTERACTIONS WITHIN THE RESPIRATORY TRACT IMPACT A PATHOGEN'S ABILITY TO COLONIZE AND CAUSE INFECTION. IN MY PRELIMINARY DATA, I DEMONSTRATE THAT S. PNEUMONIAE UNDERGOES EXTENSIVE TRANSCRIPTIONAL REPROGRAMMING UPON CO-CULTURE WITH OTHER RESPIRATORY PATHOGENS. IN ADDITION TO IDENTIFYING INTERACTIONS BETWEEN BACTERIAL SPECIES, FEW MODELS HAVE DETERMINED THE IMPACT OF INTERSPECIES COMPETITION ON SUBSEQUENT HOST RESPONSES TO A PARTICULAR PATHOGEN. A KEY GAP IN ADVANCING THIS FIELD HAS BEEN THE LACK OF EFFECTIVE MURINE MODELS OF CO-COLONIZATION, PREVENTING DETAILED IMMUNOLOGICAL AND BIOLOGICAL CHARACTERIZATION. I HAVE DEVELOPED A NOVEL MURINE CO-COLONIZATION MODEL THAT EFFECTIVELY RECAPITULATES MANY OF THE PUBLISHED CLINICAL OBSERVATIONS. FURTHERMORE, I DEMONSTRATE THAT IN VIVO CO-COLONIZATION CAN DRAMATICALLY IMPACT WHETHER PROTECTIVE CAPACITY IS GENERATED FOLLOWING COLONIZATION, SUGGESTING A CRITICAL LINK TO HOST-MEDIATED IMMUNITY. MY OVERALL GOALS ARE TO 1) LEVERAGE FUNCTIONAL GENOMICS METHODS TO DETERMINE HOW BACTERIAL VIRULENCE NETWORKS ARE ALTERED IN THE CONTEXT OF COMPLEX INFECTIOUS COLONIZATION MODELS, AND 2) DETERMINE THE EFFECT OF THESE COLONIZATION NETWORKS ON CELLULAR HOST RESPONSES FOLLOWING COLONIZATION THROUGH PROFILING OF HOST MUCOSAL RESPONSES. IN AIM 1 I WILL UTILIZE A FUNCTIONAL GENOMICS STRATEGY TO IDENTIFY PATHWAYS UTILIZED BY STREPTOCOCCUS PNEUMONIAE THAT ARE OPERATIVE DURING INTERSPECIES COMPETITION, WHICH HAS NOT BEEN ATTEMPTED IN THE CONTEXT OF A POLYMICROBIAL COLONIZATION MODEL. IN AIM 2 I WILL IDENTIFY KEY CELL POPULATIONS RESPONSIBLE FOR GENERATING PROTECTION AGAINST SUBSEQUENT INFECTION BY STREPTOCOCCUS PNEUMONIAE USING FLOW CYTOMETRY AND IDENTIFY T-CELL RECEPTOR (TCR) MOTIFS UNIQUE TO POLYMICROBIAL INFECTIONS USING A NEWLY DEVELOPED TCR REPERTOIRE SEQUENCING STRATEGY. DESPITE THE SEVERAL CLINICAL OBSERVATIONS MADE REGARDING THE HOST IMMUNE RESPONSE TO CO-INFECTION, MANY OF THESE OBSERVATIONS HAVE NOT BEEN EXPLORED MECHANISTICALLY. I HYPOTHESIZE THAT DISTINCT GENETIC DETERMINANTS AND HOST RESPONSES ARE OPERATIVE DURING INTERSPECIES COMPETITIVE MODELS OF COLONIZATION THAT IMPACT SUBSEQUENT INFECTION SUSCEPTIBILITY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $75.5k | 8/29/25 |